Adderall XR and Cognitive Impairment in MS
Adderall XR and Cognitive Impairment in MS
Active, not recruiting · NCT02676739 · Registry updated 2024-10-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adderall XR and Cognitive Impairment in MS | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 2 / Phase 3 | 2024-10-17 | NCT02676739 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sarah Morrow | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kaye Edmonton Clinic | Edmonton | Canada | 1 |
| London Health Sciences Centre | London | Canada | 28 |
| Sunnybrook Health Sciences Centre | Toronto | Canada | 167 |